Reduced EDSS progression in multiple sclerosis patients treated with modafinil for three years or more compared to matched untreated subjects
Background: Modafinil is a wakefulness-promoting drug used to treat narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. Modafinil has also been used for the treatment of fatigue and excessive sleepiness in other neurological disorders including multiple sclerosis, psychiatric disord...
Main Authors: | , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|